326 related articles for article (PubMed ID: 26821979)
1. Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain.
Borg J; Cervenka S; Kuja-Halkola R; Matheson GJ; Jönsson EG; Lichtenstein P; Henningsson S; Ichimiya T; Larsson H; Stenkrona P; Halldin C; Farde L
Mol Psychiatry; 2016 Aug; 21(8):1077-84. PubMed ID: 26821979
[TBL] [Abstract][Full Text] [Related]
2. The effect of a 5-HT1A receptor agonist on striatal dopamine release.
Bantick RA; De Vries MH; Grasby PM
Synapse; 2005 Aug; 57(2):67-75. PubMed ID: 15906386
[TBL] [Abstract][Full Text] [Related]
3. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
[TBL] [Abstract][Full Text] [Related]
4. Serotonergic neurotransmission in the living human brain: a positron emission tomography study using [¹¹C]dasb and [¹¹C]WAY100635 in young healthy men.
Takano H; Ito H; Takahashi H; Arakawa R; Okumura M; Kodaka F; Otsuka T; Kato M; Suhara T
Synapse; 2011 Jul; 65(7):624-33. PubMed ID: 21484882
[TBL] [Abstract][Full Text] [Related]
5. Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release.
Berry AS; Shah VD; Furman DJ; White RL; Baker SL; O'Neil JP; Janabi M; D'Esposito M; Jagust WJ
Neuropsychopharmacology; 2018 May; 43(6):1201-1211. PubMed ID: 28816243
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic and serotonergic mechanisms in the modulation of pain: In vivo studies in human brain.
Martikainen IK; Hagelberg N; Jääskeläinen SK; Hietala J; Pertovaara A
Eur J Pharmacol; 2018 Sep; 834():337-345. PubMed ID: 30036531
[TBL] [Abstract][Full Text] [Related]
7. The relationship between subcortical brain volume and striatal dopamine D
Caravaggio F; Ku Chung J; Plitman E; Boileau I; Gerretsen P; Kim J; Iwata Y; Patel R; Chakravarty MM; Remington G; Graff-Guerrero A
Hum Brain Mapp; 2017 Nov; 38(11):5519-5534. PubMed ID: 28752565
[TBL] [Abstract][Full Text] [Related]
8. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.
Kasper S; Tauscher J; Willeit M; Stamenkovic M; Neumeister A; Küfferle B; Barnas C; Stastny J; Praschak-Rieder N; Pezawas L; de Zwaan M; Quiner S; Pirker W; Asenbaum S; Podreka I; Brücke T
World J Biol Psychiatry; 2002 Jul; 3(3):133-46. PubMed ID: 12478878
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D
Khodaii J; Nomura Y; Chang NHS; Wong DF; Møller A; Gjedde A
Neurochem Res; 2023 May; 48(5):1517-1530. PubMed ID: 36525123
[TBL] [Abstract][Full Text] [Related]
10. Nature or nurture? Determining the heritability of human striatal dopamine function: an [18F]-DOPA PET study.
Stokes PR; Shotbolt P; Mehta MA; Turkheimer E; Benecke A; Copeland C; Turkheimer FE; Lingford-Hughes AR; Howes OD
Neuropsychopharmacology; 2013 Feb; 38(3):485-91. PubMed ID: 23093224
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of EMD 128 130 occupancy of the 5-HT1A and the D2 receptor: a human PET study with [11C]WAY-100635 and [11C]raclopride.
Rabiner EA; Gunn RN; Wilkins MR; Sedman E; Grasby PM
J Psychopharmacol; 2002 Sep; 16(3):195-9. PubMed ID: 12236624
[TBL] [Abstract][Full Text] [Related]
12. Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia.
Hirvonen J; van Erp TG; Huttunen J; Aalto S; Någren K; Huttunen M; Lönnqvist J; Kaprio J; Hietala J; Cannon TD
Arch Gen Psychiatry; 2005 Apr; 62(4):371-8. PubMed ID: 15809404
[TBL] [Abstract][Full Text] [Related]
13. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
[TBL] [Abstract][Full Text] [Related]
14. Striatal dopamine D2/3 receptor-mediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response.
Peciña M; Sikora M; Avery ET; Heffernan J; Peciña S; Mickey BJ; Zubieta JK
Eur Neuropsychopharmacol; 2017 Oct; 27(10):977-986. PubMed ID: 28870407
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
Mamo D; Graff A; Mizrahi R; Shammi CM; Romeyer F; Kapur S
Am J Psychiatry; 2007 Sep; 164(9):1411-7. PubMed ID: 17728427
[TBL] [Abstract][Full Text] [Related]
16. A positron emission tomography occupancy study of brexpiprazole at dopamine D
Girgis RR; Forbes A; Abi-Dargham A; Slifstein M
Neuropsychopharmacology; 2020 Apr; 45(5):786-792. PubMed ID: 31847007
[TBL] [Abstract][Full Text] [Related]
17. New Repeat Polymorphism in the
Shumay E; Wiers CE; Shokri-Kojori E; Kim SW; Hodgkinson CA; Sun H; Tomasi D; Wong CT; Weinberger DR; Wang GJ; Fowler JS; Volkow ND
J Neurosci; 2017 May; 37(19):4982-4991. PubMed ID: 28416594
[TBL] [Abstract][Full Text] [Related]
18. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
[TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography.
Smith GS; Ma Y; Dhawan V; Chaly T; Eidelberg D
Synapse; 2009 Jan; 63(1):1-6. PubMed ID: 18925655
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF
Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
